Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2026-04-15 @ 9:56 PM
Study NCT ID:
NCT00842712
Status:
COMPLETED
Last Update Posted:
2017-01-13
First Post:
2009-02-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Carcinoma, Non-Small-Cell Lung | View |